References

Chemo Secrets From a Breast Cancer Survivor

Breast Cancer Survivors

Get Instant Access

1. Muller J (1838) Ueber den feinern Bau und die Formen der krankhaften Geschwulste. Reimer, Berlin

2. Gurbuz AK, Giardiello FM, Petersen GM et al (1994) Desmoid tumors in familial adenomatous polyposis. Gut 35:377-381

3. Tonelli F (1978) Abdominal desmoids and mesenteric fibromatosis in familial polyposis of the colon. Ital J Gastroenterol 10:27-36

4. Simpson RD, Harrison EG, Mayo CW (1964) Mesenteric fibromatosis in familial polyposis: a variant of Gardner's syndrome. Cancer 17:526-534

5. Richards RC, Rogers SW, Gardner EJ (1981) Spontaneous mesenteric fibromatosis in Gardner's syndrome. Cancer 47: 597-601

6. Clark SK, Johnson Smith TGP, Katz DE et al (1998) Identification and progression of a desmoid precursor lesion in patients with familial adenomatous polypo-

sis. Br J Surg 85:970-975

7. Middleton SB, Clark SK, Matravers P et al (2003) Step-wise progression of familial adenomatous polyposis-associated desmoid precursor lesions demonstrated by a novel CT scoring system Dis Colon Rectum 46:481-485

8. Healey JC, Reznek RH, Clark SK et al (1997) MR appearances of desmoid tumours in familial adeno-matous polyposis. Am J Roentgenol 169:465-472

9. Brooks AP, Reznek RH, Nugent K et al (1994) CT appearances of desmoid tumors in familial adenoma-tous polyposis: further observations. Clin Radiol 49:601-607

10. Knudsen AL, Bulow S (2001) Desmoid tumour in familial adenomatous polyposis: a review of literature. Famil Cancer 1:111-119

11. Jarvinen HJ (1997) Desmoid disease as a part of familial adenomatous polyposis coli. Acta Chir Scand 153:379-383

12. Bertario L, Russo A, Sala P et al (2001) Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer 95:102-107

13. Penna C, Tiret E, Parc R et al (1993) Operation and abdominal desmoid tumors in familial adenomatous polyposis. Surg Gynecol Obstet 177:263-268

14. Jones IT, Fazio VW, Weakley FL et al (1986) Desmoid tumors in familial polyposis coli. Ann Surg 204:94-97 Lofti AM, Dozois RR, Gordon H et al (1989) Mesen-teric fibromatosis complicating familial adenomatous polyposis: predisposing factors and results of treatment. Int J Colorectal Dis 4:30-36

15. Lofti AM, Dozois RR, Gordon H et al (1989) Mesen-teric fibromatosis complicating familial adenomatous polyposis: predisposing factors and results of treatment. Int J Colorectal Dis 4:30-36

16. Rodriguez-Bigas MA, Mahoney MC, Karakousis CP et al (1994) Desmoid tumors in patients with familial adenomatous polyposis. Cancer 74:1270-1274

17. Kadmon M, Möslein G, Buhr H et al (1995) Desmoide bei Patienten mit familiärer adenomatöser Polyposis (FAP). Chirurg 66:997-1005

18. Heiskanen I, Jarvinen HJ (1997) Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment. Int J Colorectal Dis 11:157-162

19. Soravia C, Berk T, McLeod RS et al (2000) Desmoid disease in patients with familial adenomatous polypo-sis. Dis Colon Rectum 43:363-369

20. Ho JW, Chu KM, Tse CW, Yuen ST (2002) Phenotype and management of patients with familial adenoma-tous polyposis in Hong Kong: perspective of the Hereditary Gastrointestinal Cancer Registry. Hong Kong Med J 2002 Oct;8(5):342-347

21. Church JM (1998) Mucosal ischaemia caused by desmoid tumors in patients with familial adenoma-tous polyposis. Dis Colon Rectum 41: 661-663

22. Tulchinsky H, Keidar A, Strul H et al (2005) Extra-colonic manifestations of familial adenomatous poly-posis after proctocolectomy Arch Surg 140:159-163

23. Arvanitis ML, Jagelman DG, Fazio VW et al (1990) Mortality in patients with familial adenomatous poly-posis. Dis Colon Rectum 33:639-642

24. Iwama T, Myshima Y, Utsunomiya J (1993) The impact of familial adenomatous polyposis on the tumorigenesis and mortality at several organs: its rational treatment. Ann Surg 217:99-100

25. Bertario L, Presciuttini S, Sala P et al (1994) Causes of death and post-surgical survival in familial adenomatous polyposis: results from the Italian Registry of Familial Adenomatous Polyposis Writing Committee. Semin Surg Oncol 10:225-234

26. Sagar PM, Moslein G, Dozois RR (1998) Management of desmoid tumors in patients after ileal pouch-anal anastomosis for familial adenomatous polyposis. Dis Colon Rectum 41:1350-1356

27. Parc Y, Piquard A, Dozois RR et al (2004) Long-term outcome of familial adenomatous polyposis patients after restorative coloproctectomy. Ann Surg 239:378-382

28. Middleton SB, Frayling IF, Phillips RK (2000) Desmoids in familial adenomatous polyposis are monoclonal proliferations. Br J Cancer 82:828-832

29. Li C, Bapat B, Alman BA (1998) Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin regulatory function in aggressive fibromatosis (desmoid tumors). Am J Pathol 153:709-714

30. McAdam WA, Goligher IC (1970) The occurrence of desmoids in patients with familial polyposis coli. Br J Surg 57:618-631

31. Clark SK, Neale KF, Landgrebe JC et al (1999) Desmoid tumours complicating familial adenomatous polyposis. Br J Surg 86:1185-1189

32. Sturt NJH, Gallagher MC, Bassett P et al (2004) Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation. Gut 53:1832-1836

33. Caldwell EH (1976) Desmoid tumor: musculoaponeu-rotic fibrosis of the abdominal wall. Surgery 79:104-106

34. Eagel BA, Zntler-Munro P, Smith IE (1989 ) Mesenteric tumours in Gardner's syndrome: review of medical treatment. Postgrd Med J 65:497-501

35. Church JM, McGannon E (2000) Prior pregnancy ameliorates the course of intra-abdominal desmoid tumors in patients with familial adenomatous polypo-sis. Dis Colon Rectum 43:445-450

36. Miyaki M, Konishi M, Kikuchi-Yanoshita R et al (1993) Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous polyposis. Cancer Res 53:5079-5082

37. Palmirotta R, Curia MC, Esposito DL et al (1995) Novel mutations and inactivations of both alleles of the AP gene in desmoid tumors. Hum Mol Genet 4:1979-1981

38. Caspari R, Olschwang S, Friedl W et al (1995) Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 4:337-340

39. Couture J, Mitri A, Lagace R et al (2000) A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumour. Clin Genet 57:205-212

40. Eccles DM, van der Lujit R, Breukel C (1996) Heredi tary desmoid disease due to a frameshift mutation at codon 1924 of the gena APC. Am J Hum Mut 59:1193-1201

41. Tonelli F, Valanzano R, Brandi ML (1994) Pharmaco-logic treatment of desmoid tumors in familial adeno-matous polyposis: results of an in vitro study. Surgery 115:473-479

42. Picariello L, Fiorelli G, Benvenuti S et al (1997) In vitro bioeffects of the antiestrogen LY117018 on desmoid tumor and colon cancer cells. Anticancer Res 17:2099-2104

43. Locci P, Bellocchio S, Lilli C et al (2001) Synthesis and secretion of transforming growth factor-ß1 by human desmoid fibroblast cell line and its modulation by toremifene. J Interferon and Cytokine Res 21:961-970

44. Waddell WR, Gerner RE, Reich MP (1983) Non steroidal anti-inflammatory drugs and tamoxifen for desmoid tumors and carcinoma of the stomach. J Surg Oncol 22:197-211

45. Kedar RP, Bourne TH, Powles TJ et al (1994) Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 343:1318-1321

46. Fisher B, Costantino JP, Redmand CK et al(1994) Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 86:527-537

47. Clark SK, Phillips RKS (1996) Desmoids in familial adenomatous polyposis. Br J Surg 83:1494-1504

48. Brooks MD, Ebbs SR, Colletta AA et al (1992) Desmoid tumors treated with triphenylethylenes. Eur J Cancer 28:1014-1018

49. Hansmann A., Adolph C, Vogel T et al (2003) Highdose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer 100:612-620

50. Tonelli F, Ficari F, Valanzano R et al (2003) Treatment of desmoids and mesenteric fibromatosis in familial adenomatous polyposis with raloxifene. Tumori 89:391-396

51. Taketo M (1998) Cyclooxigenase-2 inhibitors in tumor-ogenesis (part i). J Natl Cancer Inst 90:1529-1536

52. Taketo M (1998) Cyclooxigenase-2 inhibitors in tumorogenesis (part II). J Natl Cancer Inst 90:1609-1620

53. Janne PA, Mayer RJ (2000) Chemoprevention of col-orectal cancer. N Engl J Med 342:1960-1968

54. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231:232-235

55. Du Bois RN, Abramson SB, Crofford L et al (1998) Cyclooxygenase in biology and disease. FASEB J 12:1063-1073

56. Smith WL, Garavito RM, DeWitt (1996) Prostaglandin endo-peroxide H synthases (Cyclooxygenase)-1 and -2. J Biol Chem 271:33157-33160

57. Xe W, Robertson D, Simmons D ( 1992) Mitogen-inducible prostaglandin G/H synthase: a new target for nonsteroidal anti-inflammatory drugs. Drug Dev Res 25:249-265

58. Morrow JD, Roberts LJ (2001) Lipid-derived auta-coids. In: Hardman JG, Limbird LE (eds) The pharmacological basis of therapeutics. McGraw-Hill, New York, pp 669-685

59. Roberts LJ, Morrow JD (2001) Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LE (eds) The pharmacological basis of therapeutics. McGraw-Hill, New York, pp 687-731

60. Patrignani P, Filabozzi P, Patrono C (1982) Selective cumulative inhibition of platelet thromboxane production by low-doses aspirin in healthy subjects. J Clin Invest 69:1366-1372

61. FitzGerald GA, Oates JA, Hawiger J et al (1983) Endogenous biosynthesis of prostacyclin and throm-boxane and platelet function during chronic administration of aspirin in man. J Clin Invest 71:678-688

62. Roth GJ, Majerus P (1975) The mechanism of the effect of aspirin on human platelets: acetylation of a particulate protein fraction. J Clin Invest 56:624-632

63. Lecomte M, Laneuville O, Ji C et al (1994) Acetylation of human prostaglandin endo-peroxide synthase-2(cyclooxygenase-2) by aspirin. J Biol Chem 269:13207-13215

64. Cipollone F, Patrignani P, Greco A et al (1997) Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulatio 96:1109-1116

65. Vane JR (1994) Towards a better aspirin. Nature 367:215-216

66. Stolina M, Sharma S, Zu L et al ( 2000) Lung cancer cyclooxygenase-2 dependent inhibition of dendritic cell maturation and function. Pro Am Assoc Cancer Res 41:619 (abstract 620)

67. Tsujii M, DuBois RN (1995) Alteration in cellular adhesion and apoptosis in epithelial cells over-expressing prostaglandin endo-peroxide synthase 2. Cell 83:493-501

68. He TC, Chan TA, Vogelstein B et al (1999) PPAR-delta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99:335-345

69. Afford S, Randhawa S (2000) Apoptosis. Mol Pathol 53:55-63

70. Bedi A, Pasricha PJ, Akhtar AJ et al (1995) Inhibition of apoptosis during development of colorectal cancer. Cancer Res 55:1811-1816

71. Pasricha PJ, Bedi A, O'Connor K et al (1995) The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gas-troenterology 109:994-998

72. Uefuji K, Ichikura T, Shinomiya N et al (2000) Induction of apoptosis by JTE-522, a specific cyclooxyge-nase-2 inhibitor in human gastric cancer cell lines. Anticancer Res 20:4279-4284

73. Souza RF, Shewmake K, Beer DG et al (2000) Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human oesophageal adenocarci-noma cells. Cancer Res 60:5767-5772

74. Sumitani K, Kamijo R, Toyoshima T et al (2001) Specific inhibition of cyclooxygenase-2 results in inhibition of proliferation of oral cancer cell lines via suppression of prostaglandin E2 production. J Oral Pathol Med 30:41-47

75. Joki T, Heese O, Nikas DC et al (2000) Expression of cyclooxygenase 2 (COX!) in human glioma and in vitro inhibition by a specific COX 2 inhibitor, NS-398. Cancer Res 60:4926-4931

76. Tsubouchi Y, Mukai S, Kawaito Y et al (2000) Meloxicam inhibits the growth of non-small cell lung cancer. Anticancer Res 20:2867-2872

77. Molina MA, Sitja-Arnau M, Lemoine MG et al (1999) Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Res 59:4356-4362

78. Marx J (2001) Cancer research. Anti-inflammatories inhibit cancer growth, but how? Science 291:581-582

79. Scorrano L, Penzo D, Petronilli V et al (2001) Arachi-donic acid causes cell death through the mitochondri-al permeability transition: implications for tumor necrosis factor-alpha apoptotic signalling. J Biol Chem 276:12035-12040

80. Grosch S, Tegeder I, Niederberg E et al (2001) COX independent induction of cell arrest and apoptosis in colon cancer cells by the selective COX 2 inhibitor celecoxib. FASEB J 15:2742-2744

81. Shureiqi I, Chen D, Lotan R et al (2000) 15-lipoxyge-nase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxyge-nase-2 in colon cancer cells. Cancer Res 60:6846-6850

82. Leahy KM, Ornberg RL, Wang et al. (2002) Cyclooxy-genase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res 62:625-631

83. Tsujii M, Kawano S, Tsujii S et al (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93:705-716

84. Dannenberg AJ, Altorki NK, Boyle JO et al (2001) Cyclo-oxygenase 2: a pharmacological target for prevention of cancer. Lancet Oncol 2:544-551

85. Araki Y, Okamura S, Hussain S et al (2003) Regulation of cyclooxygenase-2 expression by the Wnt and Ras pathways. Cancer Res 63:728-734

86. Masferrer JL, Leahy KM, Koki AT et al (2000) Anti-angiogenic and anti-tumour activities of cyclooxyge-nase-2 inhibitors. Cancer Res 60:1306-1311

87. Jones MK, Wang H, Peskar BM et al (1999) Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 5:1418-1423

88. Brueggemeier RW, Quinn AL, Parrett ML et al (1999) Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens. Cancer Lett 140:27-35

89. Tejpar S, Nollet F, Li C et al (1999) Predominance of -catenin mutations and -catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Onco-gene 18:6615-6620

90. Sparks AB, Morin PJ, Vogelstain B et al (1998) Mutational analysis of the APC/-catenin/Tcf pathway in colorectal cancer. Cancer Res 58:1130-1134

91. Williams CS, Smalley W, DuBois RN (1997) Aspirin use and potential mechanisms for colorectal cancer prevention. J Clin Invest 100:1325-1359

92. Williams CS, Mann M, DuBois RN (1999) The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18:7908-7916

93. Oshima M, Dinchuk JE, Kargman SL et al (1996) Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2

94. Picariello L, Brandi ML, Formigli L et al (1998) Apoptosis induced by sulindac sulfide in epithelial and mesenchymal cells from human abdominal neoplasms. Eur J Pharm 360:105-112

95. Poon R, Smits R, Catherine L et al (2001) Cyclooxyge-nase-two (COX2) modulates proliferation in aggressive fibromatosis (desmoid tumor). Oncogene 20:451-460

96. Tsukada K, Church JM, Jagelman DG et al (1992) Non-cytotoxic drug therapy for intra-abdominal desmoid tumors in patients with familial adenomatous polypo-sis. Dis Colon Rectum 35:29-33

97. Klein WA, Miller HH, Anderson M et al (1987) The use of indomethacin, sulindac and tamoxifen for the treatment of desmoid tumors associated with familial poly-posis. Cancer 60:2863-2868

98. Waddell WR, Kirsch WM (1991) Testolactone, sulin-dac, warfarin, and vitamin K1 for unresectable desmoid tumors. Am J Surg 161:416-421

99. Geurs F, Kok TC (1993) Regression of a great abdominal desmoid tumor by interferon-alpha. J Clin Gas-trenterol 16:264-265

100. Heidemann J, Ogawa H, Otterson MF et al (2004) Anti-angiogenic treatment of mesenteric desmoid tumors with toremifene and interferon alfa-2b: report of two cases. Dis Colon Rectum 47:118-122

101. Nakada J, Ubukata H, Goto Y et al (1997) Prednisolone therapy for intra-abdominal desmoid tumours in a patient with familial adenomatous polyposis. Gas-troenterol 32:255-259

102. Lindor NM, Dozois RR, Nelson H et al (2003) Desmoid tumors in familial adenomatous polyposis: a pilot project evaluating efficacy of treatment with pir-fenidone. Am J Gastroenterol 98:1868-1874

103. Mace J, Biermann JS, Sondak V et al (2002) Response of extra-abdominal desmoid tumors to therapy with imatinib mesylate. Cancer 95:237-239

104. Tsukada K,Church JM, Jagelman DG et al (1991) Systemic cytotoxic chemotherapy and radiation therapy for desmoid in familial adenomatous polyposis. Dis Colon Rectum 34:1090-1092

105. Patel SR, Evans HL, Benjamin RS (1992) Combination chemotherapy in adult desmoid tumors. Cancer 72:3244-3247

106. Lynch HT, Fitzgibbons R Jr, Chong S et al (1994) Use of doxorubicin and dacarbazine for the management of unresectable intraabdominal desmoid tumors in Gardner's syndrome. Dis Colon Rectum 37:260-267

107. Schnitzler M, Cohen Z Blackstein M et al ( 1997) Chemotherapy for desmoid tumors in association with familial adenomatous polyposis. Dis Colon Rectum 40:798-801

108. Risum S, Bulow S (2003) Doxorubicin treatment of an intra-abdominal desmoid tumour in a patient with familial adenomatous polyposis. Colorectal Dis 5:585-586

109. Okuno SH, Edmonson JH (2003) Combination chemotherapy for desmoid tumors. Cancer 97:1134-1135

110. Kono T, Tomita I, Chisato N et al (2004) Successful low-dose chemotherapy using vinblastine and methotrexate for the treatment of an ileoanal pouch mesenteric desmoid tumor: report of a case. Dis Colon Rectum 47:246-249

111. Gega M, Yanagi H, Yoshikawa R et al (2006) Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis. J Clin Oncol 24(1):102-105

112. Patel SR, Benjamin RS (2006) Desmoid tumors respond to chemotherapy: defying the dogma in oncology. J Clin Oncol 24:1-2

113. Hartley JE, Church JM, Gupta S et al (2004) Significance of incidental desmoids identified during surgery for familial adenomatous polyposis. Dis Colon Rectum 47:334-340

114. Cohen ZBerg T ( 1998) Invited editorial. Dis Colon Rectum 41:1355-1356

115. Tonelli F, Batignani G, Ficari F et al (1997) Straight ileo-anal anastomosis with multiple ileal myotomies as an alternative to pelvic pouch. Int J Colorectal Dis 12:261-266

Was this article helpful?

0 0
Quit Smoking For Good

Quit Smoking For Good

Quit smoking for good! Stop your bad habits for good, learn to cope with the addiction of cigarettes and how to curb cravings and begin a new life. You will never again have to leave a meeting and find a place outside to smoke, losing valuable time. This is the key to your freedom from addiction, take the first step!

Get My Free Ebook


Post a comment